Overview +

Hamartoma Serum

Hamartoma Serum is collected from IRB-consented donors diagnosed with clinically confirmed Hamartoma. These serum samples are ideal for detecting circulating biomarkers and immune signatures associated with hamartomas. These serum samples are suitable for proteomic and biomarker discovery applications related to benign tumor conditions.

Product Features

  • Cryopreserved, clinically verified hamartoma human serum samples
  • Cryopreserved to ensure stability and long-term storage
  • Research Use Only (RUO)

Donor Metadata

  • Clinically confirmed hamartoma diagnosis
  • Donor demographics: age, sex assigned at birth, ethnicity
  • Medical and treatment history available when applicable

Applications

  • Detecting circulating biomarkers and immune signatures associated with hamartomas
  • Biomarker discovery and validation
  • Transcriptomic, proteomic, or functional studies
  • Custom assay development and disease modeling

Compliance and Quality

  • IRB-approved collection and electronic informed consent
  • HIPAA-compliant donor data handling

Ordering and Customization

Hamartoma Serum is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.

Protocols and Documentation +

Document Type Technical Document
PDF > Serum Isolation

Publications +

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.